364 related articles for article (PubMed ID: 15128799)
1. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
Storni T; Bachmann MF
J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
[TBL] [Abstract][Full Text] [Related]
2. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
3. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects.
Storni T; Ruedl C; Schwarz K; Schwendener RA; Renner WA; Bachmann MF
J Immunol; 2004 Feb; 172(3):1777-85. PubMed ID: 14734761
[TBL] [Abstract][Full Text] [Related]
4. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
[TBL] [Abstract][Full Text] [Related]
5. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.
Blohm U; Roth E; Brommer K; Dumrese T; Rosenthal FM; Pircher H
J Immunol; 2002 Nov; 169(10):5522-30. PubMed ID: 12421928
[TBL] [Abstract][Full Text] [Related]
6. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
7. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
[TBL] [Abstract][Full Text] [Related]
8. Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.
Ruedl C; Storni T; Lechner F; Bächi T; Bachmann MF
Eur J Immunol; 2002 Mar; 32(3):818-25. PubMed ID: 11870626
[TBL] [Abstract][Full Text] [Related]
9. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM
J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: stimulation with the cognate self-antigen induces expression of the Ly49A receptor on self-reactive T cells which modulates their responsiveness.
Saurer L; Seibold I; Vallan C; Held W; Mueller C
J Immunol; 2003 Dec; 171(12):6334-8. PubMed ID: 14662829
[TBL] [Abstract][Full Text] [Related]
11. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
14. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
Kerry SE; Buslepp J; Cramer LA; Maile R; Hensley LL; Nielsen AI; Kavathas P; Vilen BJ; Collins EJ; Frelinger JA
J Immunol; 2003 Nov; 171(9):4493-503. PubMed ID: 14568922
[TBL] [Abstract][Full Text] [Related]
15. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
Hardy LL; Wick DA; Webb JR
J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
17. Peptidic termini play a significant role in TCR recognition.
Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
[TBL] [Abstract][Full Text] [Related]
19. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: MHC class II-restricted killing in vivo during viral infection.
Jellison ER; Kim SK; Welsh RM
J Immunol; 2005 Jan; 174(2):614-8. PubMed ID: 15634878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
